GNLX

2.1704.82%
JL

James Lee Tyree

Lead Independent Director

Mr. James Lee Tyree, also known as Jim, co-founded Tyree & D'Angelo Partners in 2013 and was its Managing Partner from 2013 to July 2020. Mr. Tyree is the Chairman and Managing Partner of Tyree Capital Partners since 2017. He serves as the Chairman and Managing Partner at Tyree & D'Angelo Partners Management LP. He is the Founder of TDP and served as its Managing Director and was its Chief Executive Officer. He has been Lead Independent Director at Genelux Corporation since July 2021 and has been its Director since May 2012. He founded TDP in 2012. He serves as an Advisor at Starboard Value LP. Mr. Tyree served as the Chief Executive Officer of Dermatology Medical Partners LLC until May 23, 2017. He is a Special Advisor to the Chancellor of UC Davis Sacramento. He has a distinguished career in health care with senior management positions at Abbvie, Abbott Laboratories, Bristol-Meyers Squibb and Pfizer. Previously, he served as Executive Vice President and President of Abbott Biotech Ventures Inc. and AbbVie Biotech Ventures, Inc. He has served as an Executive Vice President of Pharmaceutical Products Group of Abbott Laboratories from 2007 to August 1, 2009 where he held senior executive roles in the Pharmaceutical, Nutrition and International divisions. He served as the President of Abbott Nutrition International of Abbott Laboratories and Vice President of Global Licensing/New Business Development since 2001. He served as Senior Vice President of Pharmaceutical Operations for Abbott Laboratories from 2006 to 2007. Within the pharmaceutical operating division, he was integrally involved in every major transaction executed by the company. Mr. tyree identified and analyzed more than one thousand pharmaceutical in-licensing and out-licensing opportunities for Abbott and drove a substantial number of them to successful transactions. He was also directly responsible for establishing and managing Abbott Global Nutrition. Previously, he served as Senior Vice President of Abbott Nutrition International from April 2005 to 2006 and Senior Vice President, Global Nutrition since 2006. Mr. Tyree served as Divisional Vice President of Global Licensing/New Business Development from 2003 to 2005 and as Divisional Vice President and General Manager, Abbott International Division from 1998 to 2000 and its General Manger of Japan. He served as Vice President of Global Licensing/New Business Development at Abbott Laboratories since 2001. At Abbott Laboratories, he served as Corporate Vice President of Pharmaceutical and Nutritional Products Group Business Development. He served as President of Abbott Biotechnology Ventures until March 31, 2012. He was employed with Triangle Pharmaceuticals, Inc. He served as Business Analyst of Abbott from 1978 to 1979 and Corporate Officer since 2001. He rejoined Abbott in 1997. He served as President of Sugen, Inc. Mr. Tyree led the Sugen's initial public offering in 1994. He served management positions at Bristol-Myers Squibb, Pfizer and Abbott. He serves as a Co-Chairman of the Global Health Policy Roundtable. He was the Chairman of the Board at Genelux Corporation since May 2014 until 2021. Mr. Tyree was a Genelux Board Member or Observer since 2009. He served as the Chairman of Illinois Biotechnology Industry Organization. He served as Vice Chairman Innoviva, Inc. from March 1, 2017 to June 2, 2017 and served as its Director from June 2, 2014 to June 2, 2017. He was Independent Director of Assertio Holdings, Inc. (formerly Assertio Therapeutics, Inc.) from October 17, 2016 to May 2024. He serves as Director of TAP Pharmaceuticals, Theravance and iBIO Institute. He had been a Director of ChemoCentryx, Inc. since June 07, 2012 until October 20, 2022. He serves as Independent Director of SonarMed. He was a Member of Advisory Board of Exicure Inc. He serves as a Member of the Advisory Boards of the Polsky Center of Entrepreneurship at the University of Chicago and the Kellogg Center for Biotechnology at Northwestern University. He serves as Member of Richard M. Daley's Chicago Mayor's Council of Technology Advisors. He serves as a Member of the Advisory Board at the University of Chicago Booth Graduate School of Business and a Member of the Chicago Council on Global Affairs. He has an extensive senior leadership and operational experience in the pharmaceutical and biotechnology industries. He has distinguished career in health care heading global pharmaceutical products and business development in the pharmaceutical industry. Mr. Tyree earned his B.A. in psychology and forensic studies and a Master's Degree in Business Administration from Kelley School at Indiana University. He has a distinguished career in health care operations and M&A.

Positions